Cosmos Health authorizes $5M share repurchase program

Cosmos Health Inc. (NASDAQ: COSM) announced that its board of directors has authorized a share repurchase program of up to $5 million of the company's common stock.

According to a press release, the company may repurchase shares in the open market, through privately negotiated transactions, or through other permitted means in accordance with SEC Rules 10b5-1 and 10b-18. The timing and total amount of repurchases will depend on market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The program expires on December 31, 2026, and may be renewed at the company's discretion.

CEO Greg Siokas said in a statement: "This share repurchase program reflects our confidence in the Company's operating fundamentals and growth prospects." He added that the program's size represents nearly half of the company's market capitalization as of June 29, 2026.

Cosmos Health is a healthcare company that owns pharmaceutical and nutraceutical brands and distributes pharmaceuticals and parapharmaceuticals through subsidiaries in Greece and the UK.

You May Also Be Interested In

• Rezolve Ai shareholders approve $300M share repurchase program
• Sherwin-Williams climbs 18% off 52-week low as Citi sets $380 target
• Nomadar Corp. added to Russell Microcap Index in 2026 reconstitution